GTC
Ghost Tree Capital Portfolio holdings
AUM
$276M
This Quarter Return
+56.3%
1 Year Return
+49.13%
3 Year Return
+198.45%
5 Year Return
+1,783.74%
10 Year Return
+9,775.89%
AUM
$303M
AUM Growth
+$303M
(+34%)
Cap. Flow
-$50.7M
Cap. Flow
% of AUM
-16.7%
Top 10 Holdings %
Top 10 Hldgs %
52.23%
Holding
56
New
9
Increased
10
Reduced
15
Closed
12
Top Buys
| 1 |
Acadia Pharmaceuticals
ACAD
|
$8M |
| 2 |
TG Therapeutics
TGTX
|
$7.79M |
| 3 |
STSA
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
|
$6.47M |
| 4 |
Iovance Biotherapeutics
IOVA
|
$6.31M |
| 5 |
Agios Pharmaceuticals
AGIO
|
$6.15M |
Top Sells
| 1 |
Mersana Therapeutics
MRSN
|
$32.2M |
| 2 |
IMMU
Immunomedics Inc
IMMU
|
$16.8M |
| 3 |
Ascendis Pharma
ASND
|
$12.6M |
| 4 |
Axsome Therapeutics
AXSM
|
$9.46M |
| 5 |
Adverum Biotechnologies
ADVM
|
$8.47M |
Sector Composition
| 1 | Healthcare | 88.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
IMMU
1
DELISTED
Immunomedics Inc
IMMU
| $20.4M | 5.38% | 575,000 -475,000 | -45% | -$16.8M |
|
|
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $19.5M | 5.15% | 650,000 | – | – |
|
|
3
Adverum Biotechnologies
ADVM
$64.6M
| $18.8M | 4.96% | 900,000 -405,500 | -31% | -$8.47M |
|
|
MRTX
4
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $17.7M | 4.67% | 155,000 +40,000 | +35% | +$4.57M |
|
|
5
Iovance Biotherapeutics
IOVA
$807M
| $15.9M | 4.2% | 580,000 +230,000 | +66% | +$6.31M |
|
|
6
Mersana Therapeutics
MRSN
$36.5M
| $14.6M | 3.86% | 625,000 -1,375,000 | -69% | -$32.2M |
|
7
Rocket Pharmaceuticals
RCKT
$354M
| $13.6M | 3.59% | 650,000 | – | – |
|
|
MNTA
8
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $12.8M | 3.38% | 385,000 -15,000 | -4% | -$499K |
|
9
Immunovant
IMVT
$2.56B
| $12.8M | 3.37% | 525,000 -185,000 | -26% | -$4.5M |
|
|
TRIL
10
DELISTED
Trillium Therapeutics Inc.
TRIL
| $12.3M | 3.25% | 1,525,000 +700,000 | +85% | +$5.66M |
|
|
11
TG Therapeutics
TGTX
$4.65B
| $11.7M | 3.08% | 600,000 +400,000 | +200% | +$7.79M |
|
|
STSA
12
DELISTED
Satsuma Pharmaceuticals, Inc. Common Stock
STSA
| $9.78M | 2.58% | 340,000 +225,000 | +196% | +$6.47M |
|
|
13
Ascendis Pharma
ASND
$11.8B
| $9.61M | 2.54% | 65,000 -85,000 | -57% | -$12.6M |
|
14
BioCryst Pharmaceuticals
BCRX
$1.74B
| $9.05M | 2.39% | 1,900,000 -100,000 | -5% | -$477K |
|
15
Aurinia Pharmaceuticals
AUPH
$1.58B
| $8.94M | 2.36% | 550,000 +150,000 | +38% | +$2.44M |
|
|
16
Axsome Therapeutics
AXSM
$6.05B
| $8.23M | 2.17% | 100,000 -115,000 | -53% | -$9.46M |
|
|
17
Acadia Pharmaceuticals
ACAD
$4.38B
| $8M | 2.11% | +165,000 | New | +$8M |
|
|
RETA
18
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $7.8M | 2.06% | 50,000 | – | – |
|
|
AVDL
19
Avadel Pharmaceuticals
AVDL
$1.43B
| $6.67M | 1.76% | 825,000 +475,000 | +136% | +$3.84M |
|
|
MYOV
20
DELISTED
Myovant Sciences Ltd.
MYOV
| $6.19M | 1.63% | 300,000 -285,000 | -49% | -$5.88M |
|
|
21
Agios Pharmaceuticals
AGIO
$2.19B
| $6.15M | 1.62% | +115,000 | New | +$6.15M |
|
22
Wave Life Sciences
WVE
$1.53B
| $5.57M | 1.47% | +535,000 | New | +$5.57M |
|
|
SURF
23
DELISTED
Surface Oncology, Inc. Common Stock
SURF
| $4.59M | 1.21% | +700,000 | New | +$4.59M |
|
|
ISEE
24
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $4.59M | 1.21% | 900,000 +71,541 | +9% | +$365K |
|
25
Fate Therapeutics
FATE
$120M
| $4.29M | 1.13% | 125,000 -100,000 | -44% | -$3.43M |
|